Products

What will AGI do for Allylestrenol?

This classification denotes a therapeutic progestin with the molecular formula C21H32O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I47VB5DZ8O, chemically known as 19-nor-17-alpha-preg-4-en-17-ol, 21-methylene- but generally known as allylestrenol, which bears US NIH Compound Identifier 9896. European Medicines Agency schedules Allylestrenol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05339MIG. The term ALLYLESTRENOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules allylestrenol in its Anatomical Therapeutic Chemical (ATC) Classification. ALLYLESTRENOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule allylestrenol under HS 29372300 and SITC 54153. As of Q4 2014, ALLYLESTRENOL remains the US FDA Preferred Term for this commodity. Allylestrenol bears US NLM identifiers UMLS ID C0002158 and NCI Concept Code C80270. SMILES: OC1(C2(C(C3C(CC2)C2C(=CCCC2)CC3)CC1)C)CC=C.